The predictive role of aortic propagation velocity for coronary artery disease

Fereshteh Ghaderi1, Hossein Samim2, Faeze Keihanian3,4

  • 1Fellowship in echocardiography, Cardiology Department, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Insights

Aortic propagation velocity (APV) is a novel echocardiographic marker for aortic stiffness. Lower APV levels correlate with coronary artery disease (CAD) presence and severity, suggesting its potential as a predictive tool for cardiovascular risk.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Vascular Biology

Background:

  • Cardiovascular risk factors induce aortic changes, with aortic stiffness predicting morbidity and mortality.
  • Aortic stiffness, a key cardiovascular risk factor, is assessed using various parameters.
  • Aortic propagation velocity (APV) is an under-evaluated echocardiographic measure of aortic stiffness.

Purpose of the Study:

  • To investigate the relationship between aortic propagation velocity (APV) and the presence/severity of coronary artery disease (CAD).
  • To evaluate APV as a potential echocardiographic marker for aortic stiffness in patients undergoing coronary angiography.

Main Methods:

  • A cross-sectional study involving 70 patients undergoing elective coronary artery angiography.
  • Patients were categorized into CAD (n=38) and non-CAD (n=32) groups based on angiography.
  • Transthoracic echocardiography was used to measure APV, aortic strain (AS), and aortic distensibility (AD).

Main Results:

  • Aortic strain, distensibility, and APV were significantly lower in the CAD group compared to the non-CAD group (P<0.0001).
  • APV demonstrated a significant inverse relationship with CAD presence and severity.
  • An APV cutoff of <56 cm/sec predicted CAD with 96.9% sensitivity and 78.9% specificity.

Conclusions:

  • Aortic strain, distensibility, and APV are inversely correlated with the presence and severity of CAD.
  • APV is a valuable echocardiographic index for assessing aortic stiffness and its association with CAD.
  • APV may serve as a useful predictor for detecting CAD and evaluating its severity.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
504
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
292
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
404
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
709
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
387